Orphan Technologies is open to partnering opportunities.

We understand that developing first-in-class therapies requires collaborating with the medical community, academic researchers, and patient groups. Fostering long-term partnerships to advance patient care is part of our DNA and we are always looking to expand our pipeline with new innovative products targeting rare and ultra-rare diseases.

For more information, please contact